Medical and surgical management of thyroid nodules
-
Upload
brucelee55 -
Category
Health & Medicine
-
view
635 -
download
7
Transcript of Medical and surgical management of thyroid nodules
![Page 1: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/1.jpg)
Thyroid nodules - medical and surgical management
JRE Davis NR Parrott
Endocrinology and Endocrine Surgery
Manchester Royal Infirmary
![Page 2: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/2.jpg)
Thyroid nodules - prevalence
Thyroid nodules common, increase with age
30-60% of thyroids have nodules at autopsy
Palpation: 5-20% (>1cm)
U/S: 15-50% (>2mm)
![Page 3: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/3.jpg)
Thyroid cancer - prevalence
Thyroid cancer rare
Prevalence estimated <0.1% in USA
1.5% of all new cancers
0.2% of cancer deaths
Occult thyroid cancer also rare:
~4% incidental finding at autopsy
![Page 4: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/4.jpg)
Thyroid nodules - pathogenesis
Histology:adenoma - follicular, Hürthle cellcystcolloid nodulelymphocytic thyroiditisthyroid cancerlymphoma
Iodine deficiency, radiationTSH-R and Gs mutations (cAMP
signal pathway)
![Page 5: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/5.jpg)
Clinical signs - important features
Age, iodine status, radiation exposure
Thyroid status
Presence of goitre, ?multinodular disease
Pressure symptomsMobility, skin tetheringLymph nodesRLN palsy
![Page 6: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/6.jpg)
Evaluation of thyroid nodules
Frequent benign disease, low risk of malignancy
Which nodules to evaluate?
Solitary nodules >1cm in euthyroid patients(rule out Graves, Hashimoto’s; risk in children)
Dominant nodules >1.5cm in MNG
Once subjected to FNA: 10-20% risk of suspicious cytology, therefore thyroid surgery95% of histology will be benign, and surgery “unnecessary”
![Page 7: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/7.jpg)
Diagnostic approach - isotope scan
cold nodules: higher risk of malignancy
but 80% of nodules are “cold”
small cold nodules may be missed
hot nodules may be malignant
...therefore rarely used for evaluation
![Page 8: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/8.jpg)
Diagnostic approach - FNA
22-25 gauge needle
10-20cc syringe
syringe holder?
plain glass slides, frosted end
technique: liaison with cytologist!
U/S guided FNA?
![Page 9: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/9.jpg)
Diagnostic approach - FNA outcome
Unsatisfactory
inadequate cellularity: 5-20%
Benign
~70%: usually colloid nodules
Suspicious
10-20%: “follicular neoplasm”...
could be adenoma or carcinoma
Malignant
5%, mostly papillary carcinoma
rarer: MTC, lymphoma, metastasis
![Page 10: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/10.jpg)
Diagnostic approach - ultrasound
Identifies solid v. cystic nodules
Identifies MNG
May aid FNA
Does not exclude malignancy
![Page 11: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/11.jpg)
Diagnostic approach - other tests
Calcitoninvery high results diagnostic for MTCrisk of borderline false positives
not for routine use
Thyroglobulinnot helpful for exclusion of carcinoma:
overlap with benign diseasebest for follow-up after thyroidectomy
![Page 12: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/12.jpg)
Management of the solitary nodule
N o
W atch ?
B en ig n
S u rg ery
M alig n an t
In d e te rm in a te
S u rg ery
R ep eat F N A C
In d e te rm in a te
S u rg ery
F o llicu la r
F N A C
Y es
Tru e so lita ry n od u le?
![Page 13: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/13.jpg)
Surgical strategy for the solitary nodule
• Undiagnosed / uncertain or follicular on FNAC
Total lobectomy and isthmusectomy
Frozen section ???
Leave contralateral ‘virgin’
![Page 14: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/14.jpg)
THYROID MALIGNANCY
TYPE AGE FREQUENCYSURVIVAL
PAPILLARY 20-30 50-60% 99%
FOLLICULAR40-50 20% 50%
MEDULLARY35-50 5% 40%
ANAPLASTIC50+ 5% 0%
LYMPHOMA 40-50 10% 50%
![Page 15: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/15.jpg)
Papillary carcinoma
Age 20-30
Often indolent and slow growing.
Lymph node metastases early
Lateral aberrant thyroid!
Multicentricity the rule
Excellent prognosis
?TSH dependent
![Page 16: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/16.jpg)
Follicular carcinoma
Age 40-50
5 year survival 50-70%
Blood spread (bones and lungs)
Not multifocal
?TSH dependent
![Page 17: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/17.jpg)
Medullary carcinoma
Variable age (Sporadic/MEN)
Parafollicular cells
Calcitonin
Associated with phaeochromocytoma etc.
Spread by blood and lymph
![Page 18: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/18.jpg)
Anaplastic carcinoma
More elderly (50-60)
Rapid progression
Rapid local invasion
Surgery not usually possible
High mortality, most die < 1 year
![Page 19: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/19.jpg)
Thyroid lymphoma
Any age
Isolated or generalised
Early local invasion is usual
Radiotherapy / chemotherapy treatment of choice
![Page 20: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/20.jpg)
Management of thyroid carcinoma, a) Papillary carcinoma
Total thyroidectomy
Central neck clearance
Block dissection if lateral neck nodes palpable
I131 scanClear, no action
Hot spot, ablative dose I131
![Page 21: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/21.jpg)
Why do a total thyroidectomy in papillary carcinoma?
Disease is multifocal, bi-lobar in 30-70% cases.
Value of thyroglobulin
Increased efficacy of radio-ablation
Morbidity of surgery should not be increased
![Page 22: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/22.jpg)
Management of thyroid carcinoma, b) Follicular carcinoma
Total thyroidectomy
Central neck clearance
Block dissection if lateral neck nodes palpable
I131 scanClear, no action
Hot spot, ablative dose I131
![Page 23: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/23.jpg)
Management of thyroid carcinoma;c) Medullary
Total thyroidectomy (disease often multifocal)
Slightly more extensive central neck clearance (nodes involved in 75%)
![Page 24: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/24.jpg)
Management of thyroid carcinoma;d) Lymphoma
Surgery to establish diagnosis
Radiotherapy
Chemotherapy
![Page 25: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/25.jpg)
MACIS score for Papillary thyroid carcinoma
Index Calculation Score
Age + 3.1 for <39
0.08 x age for > 40
Size 0.3 x size (cm)
Incomplete
Resection
+1
Local invasion
+1
Distant metastases
+3
TOTAL
![Page 26: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/26.jpg)
Predictive value of MACIS score
Score 20 year survival
<6 99%
6.00 – 6.99 89%
7.00 – 7.99 56%
> 8.00 24%
![Page 27: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/27.jpg)
TNM classification of thyroid cancerPrimary tumour
- T1 < 1cm
- T2 1-4 cm
- T3 > 4 cm
- T4 Beyond thyroid capsule
Regional Lymph nodes
- NX Not assessable
- N0 No regional nodes
- N1 Regional nodes involved
* N1a Ipsilateral cervical nodes
* N1b bilateral, contralateral, midline nodes
Distant metastases
- Mx Cannot be assessed
- M0 None
- M1 Present
![Page 28: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/28.jpg)
Complications of surgery?
1. Haemorrhage
2. Hypothyroidism
3. Hypocalcaemia4. RLN palsy
5. Infection
6. Mortality
![Page 29: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/29.jpg)
Thyroid surgery- technical hints
Always identify recurrent nerve throughout
Avoid ‘bulk ligation’ of superior pedicle
Never divide trunk of inferior thyroid artery
Unless malignant, dissect on the capsule
Always preserve parathyroids
Auto-transplant if necessary
![Page 30: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/30.jpg)
PEARLS
50% of solitary nodules are not
90% of thyroid swellings are benign
Never assume
Solitary nodules in men more often malignant
Children < 14 with solitary nodule, 50% malignant
![Page 31: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/31.jpg)
What are the standards set for thyroid surgery?
The indications for operation, risks and complications should be discussed with patients prior to surgery
Fine needle aspiration cytology should be performed routinely in investigation of solitary thyroid nodules
Recurrent laryngeal nerve should be routinely identified
All patients scheduled for re-operative thyroid surgery should have ENT examination
All with post-operative voice change should have vocal cords examined
Permanent vocal cord palsy should be < 1%
Post-operative haemorrhage should be <5%
All cancer should be treated by a multi-disciplinary team
![Page 32: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/32.jpg)
What operative experience is necessary for accreditation in endocrine surgery?
Performed Assisted
Thyroid lobectomy
20 30
Parathyroid
10 20
*Must spend one year in accredited unit*
![Page 33: Medical and surgical management of thyroid nodules](https://reader036.fdocuments.in/reader036/viewer/2022062313/558ba976d8b42a38568b458a/html5/thumbnails/33.jpg)
What is necessary to be recognised as a training unit in endocrine surgery?
Approved by BAESOne or more surgeons with
declared interest in endocrine surgery
An annual operative throughput of >50 patients
On site cytology and histopathologyAt least one consultant
endocrinologist, at least 1 endocrine clinic/week
Nuclear Medicine on siteMRI and CT on site